ÂÜÀòÂÒÂ×

Sherry Elchin serves as the Chief Operating Officer at Britecyte Inc. since January 2022, also acting as a consultant for Regenerative and Cell Therapies. Prior to this role, Sherry held various leadership positions at Smith+Nephew, including 3rd Party BioTissue Leader and Director of Donor Services, where responsibilities encompassed managing external CMO operations and tissue banking activities. At Osiris Therapeutics, Sherry's extensive experience spanned roles such as VP of Technical Services, Director of Donor Services, and Senior Manager of Compliance, focusing on operational compliance, tissue procurement, and product development. Sherry's educational background includes a Master's degree in Biotechnology from The Johns Hopkins University and a Bachelor's degree in Biology from the University of Pittsburgh.